Table 4.
Analyte | Cmax (ng/ml) | Tmax (min) | AUC0-t (min ng/ml) |
---|---|---|---|
| |||
Sorafenib | 154.3 ± 30.4 | 60.0 ± 40.6 | 33489.4 ± 6766.4 |
Pazopanib | 717.0 ± 205.5 | 97.5 ± 66.5 | 248812.5 ± 65971.3 |
Analyte | Cmax (ng/ml) | Tmax (min) | AUC0-t (min ng/ml) |
---|---|---|---|
| |||
Sorafenib | 154.3 ± 30.4 | 60.0 ± 40.6 | 33489.4 ± 6766.4 |
Pazopanib | 717.0 ± 205.5 | 97.5 ± 66.5 | 248812.5 ± 65971.3 |